Artal Group S.A.
- SEC CIK
- 0001053906
- 最新申報
- 2026/8/13
2021 年第 2 季持倉
持倉截至 2021/6/30，2021/8/13 申報。只含多頭部位，變化是跟 2021 年第 1 季比股數。
- 持股檔數
- 138
- 較 2021 年第 1 季 +5
- 總值
- $43.9 億
- 較 2021 年第 1 季 −$3.31 億 (−7.0%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| CDTXCidara Therapeutics, Inc. | COM | 224,675 | $45.4 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| LULufax Holding Ltd | ADS REP SHS CL A | 50,000 | $56.5 萬 | <0.1% | +50,000 | 新進 | 歷史 |
| SURFSurface Oncology, Inc. | COM | 100,000 | $74.6 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Cerevel Therapeutics HLDNG I15678U102 | *W EXP 06/09/202 | 79,600 | $114.5 萬 | <0.1% | 00.0% | 不變 | – |
| RIGLRigel Pharmaceuticals Inc | COM NEW | 321,100 | $139.4 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | 110,532 | $142.3 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Chiasma, Inc16706W102 | COM | 380,000 | $179.7 萬 | <0.1% | 00.0% | 不變 | – |
| MOLNMolecular Partners AG | ADS | 100,000 | $204.9 萬 | <0.1% | +100,000 | 新進 | 歷史 |
| LVTXLAVA Therapeutics NV | SHS | 200,000 | $217.6 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| KAKineta, Inc. | COM | 217,391 | $253.3 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| KDNYChinook Therapeutics, Inc. | COM | 180,500 | $254.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 100,000 | $257.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| LITSLite Strategy, Inc. | COM NEW | 1,000,000 | $285.0 萬 | 0.1% | +240,000+31.6% | 加碼 | 歷史 |
| AXLAAxcella Health Inc. | COM | 712,500 | $285.7 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| KNTEKinnate Biopharma Inc. | COM | 125,000 | $291.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SGTXSigilon Therapeutics, Inc. | COM | 276,000 | $296.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Paramount Global92556H206 | CL B | 75,000 | $339.0 萬 | 0.1% | +7,500+11.1% | 加碼 | – |
| MTCRMetacrine, Inc. | COM | 924,898 | $351.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 142,500 | $352.1 萬 | 0.1% | 00.0% | 不變 | – |
| CDAKCodiak BioSciences, Inc. | COM | 200,000 | $370.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| KLDOKaleido Biosciences, Inc. | COM | 500,500 | $372.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| IMMPIMMUTEP Ltd | SPONSORED ADS | 1,000,000 | $387.0 萬 | 0.1% | +1,000,000 | 新進 | 歷史 |
| MREOMereo BioPharma Group plc | SPON ADS | 1,500,000 | $475.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| MCRBSeres Therapeutics, Inc. | COM | 200,000 | $477.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 431,894 | $489.3 萬 | 0.1% | +431,894 | 新進 | 歷史 |
| CYPHCypherpunk Technologies Inc. | COM | 3,000,000 | $492.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Dynamics Special Purpose Cor268010105 | CLASS A COM | 500,000 | $497.0 萬 | 0.1% | +500,000 | 新進 | – |
| CRDFCardiff Oncology, Inc. | COM | 750,000 | $498.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| NEUENeueHealth, Inc. | COM | 305,555 | $524.3 萬 | 0.1% | +305,555 | 新進 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 593,030 | $533.7 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| HOOKHOOKIPA Pharma Inc. | COM | 599,616 | $549.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| FUSNFusion Pharmaceuticals Inc. | COM | 750,000 | $606.0 萬 | 0.1% | +210,736+39.1% | 加碼 | 歷史 |
| CFRXCONTRAFECT Corp | COM NEW | 1,500,000 | $660.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SPROSpero Therapeutics, Inc. | COM | 500,000 | $698.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ORICOric Pharmaceuticals, Inc. | COM | 400,000 | $707.6 萬 | 0.2% | +300,000+300.0% | 加碼 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM | 1,045,000 | $727.3 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 260,500 | $728.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 200,000 | $730.0 萬 | 0.2% | +200,000 | 新進 | 歷史 |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 200,000 | $732.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Omega Alpha SpacG6749V107 | CL A | 750,000 | $746.3 萬 | 0.2% | 00.0% | 不變 | – |
| IMCRImmunocore Holdings plc | ADS | 200,000 | $781.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ARAVAravive, Inc. | COM | 1,311,291 | $784.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SANASana Biotechnology, Inc. | COM | 400,000 | $786.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ORTXOrchard Therapeutics plc | ADS | 1,803,858 | $791.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ACIUAC Immune SA | SHS | 1,000,000 | $793.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| DSGNDesign Therapeutics, Inc. | COM | 400,000 | $795.6 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SLDBSolid Biosciences Inc. | COM | 2,250,000 | $823.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| APLTApplied Therapeutics, Inc. | COM | 400,000 | $831.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| STOKStoke Therapeutics, Inc. | COM | 250,000 | $841.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IMUXImmunic, Inc. | COM | 700,000 | $858.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| TILInstil Bio, Inc. | COM | 450,000 | $869.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| YI111, Inc. | ADS | 966,349 | $877.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 100,000 | $879.6 萬 | 0.2% | +100,000 | 新進 | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM | 1,700,000 | $926.5 萬 | 0.2% | +675,000+65.9% | 加碼 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 2,500,000 | $977.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 500,000 | $989.5 萬 | 0.2% | +500,000 | 新進 | 歷史 |
| VORVor Biopharma Inc. | COM | 550,000 | $1,026 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CRISCuris Inc | COM NEW | 1,300,000 | $1,049 萬 | 0.2% | −504,729−28.0% | 減碼 | 歷史 |
| ADVMAdverum Biotechnologies, Inc. | COM | 3,000,000 | $1,050 萬 | 0.2% | +600,000+25.0% | 加碼 | 歷史 |
| KRSAKorsana Biosciences, Inc. | COM | 2,779,122 | $1,084 萬 | 0.2% | +961,538+52.9% | 加碼 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 525,000 | $1,105 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| LYELLyell Immunopharma, Inc. | COM | 700,000 | $1,137 萬 | 0.3% | +700,000 | 新進 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 250,000 | $1,213 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| AGLagilon health, inc. | COM | 300,000 | $1,217 萬 | 0.3% | +300,000 | 新進 | 歷史 |
| TCRRTCR2 Therapeutics Inc. | COM | 750,000 | $1,231 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| KURAKura Oncology, Inc. | COM | 600,000 | $1,251 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| AUPHAurinia Pharmaceuticals Inc. | COM | 1,000,000 | $1,296 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| YMABY-mAbs Therapeutics, Inc. | COM | 400,000 | $1,352 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ADAGAdagene Inc. | ADS | 1,000,000 | $1,356 萬 | 0.3% | +200,000+25.0% | 加碼 | 歷史 |
| EVLOEvelo Biosciences, Inc. | COM | 1,000,000 | $1,374 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| Translate Bio, Inc.89374L104 | COM | 500,000 | $1,377 萬 | 0.3% | −500,000−50.0% | 減碼 | – |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,000,000 | $1,378 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| HARPHarpoon Therapeutics, Inc. | COM | 1,000,000 | $1,387 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| LFSTLifeStance Health Group, Inc. | COM | 500,000 | $1,393 萬 | 0.3% | +500,000 | 新進 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 400,000 | $1,464 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 4,750,000 | $1,477 萬 | 0.3% | 00.0% | 不變 | – |
| DLOdLocal Ltd | CLASS A COM | 295,000 | $1,550 萬 | 0.4% | +295,000 | 新進 | 歷史 |
| IQiQIYI, Inc. | SPONSORED ADS | 1,000,000 | $1,558 萬 | 0.4% | −25,000−2.4% | 減碼 | 歷史 |
| ZYMEZymeworks Inc. | COM | 450,000 | $1,561 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 1,200,000 | $1,630 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 850,000 | $1,666 萬 | 0.4% | +850,000 | 新進 | 歷史 |
| RNACCartesian Therapeutics, Inc. | COM | 4,000,000 | $1,672 萬 | 0.4% | −500,000−11.1% | 減碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 275,000 | $1,676 萬 | 0.4% | +25,000+10.0% | 加碼 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 550,000 | $1,715 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| APTXAptinyx Inc. | COM | 6,116,493 | $1,731 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 1,000,000 | $1,794 萬 | 0.4% | +200,000+25.0% | 加碼 | 歷史 |
| FHTXFoghorn Therapeutics Inc. | COM | 1,720,720 | $1,836 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| GOSSGossamer Bio, Inc. | COM | 2,358,968 | $1,916 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| NEXINexImmune, Inc. | COM | 1,200,000 | $1,958 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 1,646,517 | $2,007 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| NGNovagold Resources Inc | COM NEW | 2,600,000 | $2,083 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| ALBOAlbireo Pharma, Inc. | COM | 600,000 | $2,111 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| LENZLENZ Therapeutics, Inc. | COM | 700,000 | $2,151 萬 | 0.5% | +700,000 | 新進 | 歷史 |
| IMAImageneBio, Inc. | COM | 1,549,513 | $2,176 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM | 1,200,000 | $2,194 萬 | 0.5% | +450,000+60.0% | 加碼 | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,040,882 | $2,207 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,255,375 | $2,208 萬 | 0.5% | 00.0% | 不變 | – |
| SQZSQZ Biotechnologies Co | COM | 1,606,309 | $2,321 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| ATRAAtara Biotherapeutics, Inc. | COM | 1,500,000 | $2,333 萬 | 0.5% | −500,000−25.0% | 減碼 | 歷史 |
| CARAvis Budget Group, Inc. | COM | 300,000 | $2,337 萬 | 0.5% | −150,000−33.3% | 減碼 | 歷史 |
選擇權（6 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2021 年第 1 季之後清倉（14 檔）
2021 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 1 季股數 | 2021 年第 1 季市值 | 2021 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| BNTXBioNTech SE | SPONSORED ADS | 900,000 | $9,827 萬 | 2.1% | 歷史 |
| INTCIntel Corp | Stock | 800,000 | $5,120 萬 | 1.1% | 歷史 |
| ChemoCentryx, Inc.16383L106 | COM | 750,000 | $3,843 萬 | 0.8% | – |
| AVGOBroadcom Inc. | Stock | 75,000 | $3,478 萬 | 0.7% | 歷史 |
| BEKEKE Holdings Inc. | SPONSORED ADS | 600,000 | $3,419 萬 | 0.7% | 歷史 |
| CPNGCoupang, Inc. | CL A | 400,000 | $1,974 萬 | 0.4% | 歷史 |
| ZZillow Group, Inc. | CL C CAP STK | 100,000 | $1,296 萬 | 0.3% | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 400,000 | $1,266 萬 | 0.3% | 歷史 |
| TMETencent Music Entertainment Group | SPON ADS | 550,000 | $1,127 萬 | 0.2% | 歷史 |
| TCOMTrip.com Group Ltd | ADS | 250,000 | $990.8 萬 | 0.2% | 歷史 |
| GDSGDS Holdings Ltd | SPONSORED ADS | 100,000 | $810.9 萬 | 0.2% | 歷史 |
| SHLSShoals Technologies Group, Inc. | CL A | 100,000 | $347.8 萬 | 0.1% | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 75,000 | $194.3 萬 | <0.1% | 歷史 |
| MANUManchester United plc | ORD CL A | 12,488 | $19.7 萬 | <0.1% | 歷史 |